Goat Anti-Human IgG+IgM+IgA H&L (HRP) (ab102420)
Key features and details
- Goat Anti-Human IgG+IgM+IgA H&L (HRP)
- Conjugation: HRP
- Host species: Goat
- Isotype: IgG
- Suitable for: IHC-P, ELISA, WB, ICC
製品の概要
-
製品名
Goat Anti-Human IgG+IgM+IgA H&L (HRP)
IgG + IgM + IgA 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Human -
特異性
By immunoelectrophoresis and ELISA this antibody reacts with human IgG, IgA and IgM. No antibody was detected against non-immunoglobulin serum proteins. This antibody may cross react with immunoglobulins from other species. -
アプリケーション
適用あり: IHC-P, ELISA, WB, ICCmore details -
免疫原
Other Immunogen Type corresponding to IgG + IgM + IgA.
-
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.8
Constituents: 0.2% BSA, 0.05% CMIT/MIT based preservative -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to HRP. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab102420の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
IHC-P |
1/200 - 1/5000.
|
|
ELISA |
1/10000 - 1/100000. ELISA - Primary
|
|
WB |
1/5000 - 1/50000. WB - Colorimetric: 1/5000 - 1/30000; WB - Chemiluminescent: 1/10000 - 1/50000
|
|
ICC |
Use at an assay dependent dilution.
|
特記事項 |
---|
IHC-P
1/200 - 1/5000. |
ELISA
1/10000 - 1/100000. ELISA - Primary |
WB
1/5000 - 1/50000. WB - Colorimetric: 1/5000 - 1/30000; WB - Chemiluminescent: 1/10000 - 1/50000 |
ICC
Use at an assay dependent dilution. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (3)
ab102420 は 3 報の論文で使用されています。
- Esperança-Martins M et al. Humoral Immune Response of SARS-CoV-2-Infected Patients with Cancer: Influencing Factors and Mechanisms. Oncologist 26:e1619-e1632 (2021). PubMed: 34018280
- Figueiredo-Campos P et al. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. Eur J Immunol 50:2025-2040 (2020). PubMed: 33084029
- Abbasnia T et al. Isolation and purification of glycosylphosphatidylinositols (GPIs) in the schizont stage of Theileria annulata and determination of antibody response to GPI anchors in vaccinated and infected animals. Parasit Vectors 11:82 (2018). PubMed: 29409517